SH PHARMA 02607Hong Kong Stock Exchange

11.0301.19%( +0.130 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SH PHARMA (02607) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2011-05-20
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000012B3
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)332.54B1/112
Net Profit (Last FY)6.71B5/125
ROE (Last FY)7.54%35/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Shanghai Pharmaceuticals Holding Co., Ltd. Executive Director
杨秋华 Executive Director
沈波 Executive Director
李永忠 Executive Director
董明 Executive Director
张文学 Non-Executive Director
赵勇 Non-Executive Director
王忠 Independent Non-Executive Director
万钧 Independent Non-Executive Director
薛云奎 Independent Non-Executive Director
王迁 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-25.

About this page

This page shows SH PHARMA (02607) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.